We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PTAB Sides With Amneal on Obviousness of Purdue’s Oxycontin Patent
PTAB Sides With Amneal on Obviousness of Purdue’s Oxycontin Patent
The PTO’s Patent Trial and Appeal Board ruled against a Purdue Pharma patent on OxyContin, agreeing with Amneal Pharmaceuticals on the patent’s obviousness.